Assistant Professor Department of Radiology at NYU Grossman School of Medicine
New York, NY
Medical Director
Genitourinary Cancer Research
Tennessee Oncology, Nashville, TN
Professor of Surgery, Residency Program Director and a member of the Section of Urologic Oncology in the Glickman Urological and Kidney Institute at Cleveland Clinic
Cleveland, OH
Professor of Radiation Oncology at Harvard Medical School
Vice-Chair of Faculty & Academic Affairs and Director of the Genitourinary (GU) Division Department of Radiation Oncology and Clinical Co-Director of The Claire and John Bertucci Center for GU Cancers at Massachusetts General Hospital, Boston, MA
Section Head, Bladder Cancer
Genitourinary Oncology, Early Drug Development
Memorial Sloan Kettering Cancer Center, New York, NY
George Gabriel and Francis Gabie Villere Distinguished Professor of Medicine
Vice Chief for Research Medicine
Section Chief Genitourinary Oncology
UNC School of Medicine
Chapel Hill, NC
James H. Semans, M.D. Distinguished Professor of Urologic Surgery, in the School of Medicine, Urology
Professor of Urology
Professor in Anesthesiology Anesthesiology
Duke University Medical Center, Durham, NC
Pap Corps Champions for Cancer Research Endowed Chair in Solid Tumor Research
Professor and Vice Chair of Research
Desai Sethi Urology Institute
Assistant Director of Clinical Research
Sylvester Comprehensive Cancer Center
University of Miami, Miller School of Medicine
Miami, FL
Professor, Department of Surgery (Urology), University of Toronto
Director of Uro-Oncology, Mount Sinai Hospital
Surgeon, Princess Margaret Cancer Centre, University Health Network
Director, Uro-Oncology Fellowship Program, University of Toronto
Director of the Bladder Cancer Research Program, Toronto, Ontario, Canada
8:00 – 10:00am Registration/Exhibit Space Open
10:00 -10:45am Contemporary Surgical Management of Renal Cell Carcinoma
Steven Campbell, MD, PhD – Cleveland Clinic
10:45 – 11:00 am Questions & Answers
11:00 – 11:45 am Systemic Therapy for Renal Cell Carcinoma: Immunotherapy vs Immunotherapy & TKIs
Kathryn Beckermann, MD, PhD – Tennessee Oncology
11:45 – 12:00 pm Questions & Answers
12:00 – 1:00 pm Lunch (sponsored with speaker non-CME)
1:00 – 1:45 pm Management of Muscle-Invasive Bladder Cancer
Matthew Milowsky, MD, FASCO - UNC
1:45 – 2:00 pm Questions & Answers
2:00 – 2:45 pm Update on Diagnosis, Risk Assessment and Surgical Management of Localized Prostate Cancer 2024
Judd Moul, MD – Duke
2:45 – 3:00 pm Questions & Answers
3:00 – 3:45 pm Role of Next-Generation Imaging in Treatment for Advanced Prostate Cancer
Anton Becker, MD, PhD – NYU Langone
3:45 – 4:00 pm Questions & Answers
8:00 – 9:00 am Breakfast (sponsored with speaker non-CME)
9:00 – 9:45 am High Risk Locally Advanced Oligometastatic Disease
Jason Efstathiou, MD, DPhil – Harvard
9:45 – 10:00 am Questions & Answers
10:00 – 10:45 am Metastatic Bladder Cancer: Immunologic & Targeted Approaches
Gopa Iyer, MD – MSKCC
10:45 – 11:00 am Questions & Answers
11:00 – 11:45 am Trimodality Therapy in Bladder Cancer
Alex Zlotta, MD, PHD, FRCSC– Mt Sinai
11:45 – 12:00 pm Questions & Answers
12:00 – 1:00 pm Lunch (sponsored with speaker non-CME)
1:00 – 1:45 pm Theranostics in Prostate Cancer
Sanoj Punnen, MD, MAS - University of Miami
1:45 – 2:00 pm Questions & Answers
2:00 – 2:45 pm Proton vs Photon Therapy in Prostate Cancer
Jason Efstathiou, MD, DPhil - Harvard
2:45 – 3:00 pm Questions & Answers
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.